Seeking Alpha
0
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Navidea's Macrophage Therapeutics Gets A $2.5 Million Vote Of Confidence

In a press release that went out on January 21, Navidea Biopharmaceuticals (NYSEMKT:NAVB) announced financing plans for its newly created Macrophage Therapeutics unit. MT was created to explore ways to leverage the company's Manocept platform to create macrophage-targeted therapies for a wide array of applications including oncology, inflammatory, autoimmune, and cardiovascular applications. More information on Manocept can be found here and here. The agreement has yet to be finalized but there are definite positive takeaways for…